MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo (Q38837212)

6 September 2017

MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo (English)

1 reference

6 September 2017

1 reference

1 reference

Qi-Guang Chen

1

1 reference

6 September 2017

Wei Zhou

2

1 reference

6 September 2017

Tao Han

3

1 reference

6 September 2017

Shu-Qi Du

4

1 reference

6 September 2017

Zhen-Hua Li

5

1 reference

6 September 2017

Zhe Zhang

6

1 reference

6 September 2017

Guang-Yi Shan

7

1 reference

6 September 2017

Chui-Ze Kong

8

1 reference

6 September 2017

7 September 2015

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

2

1 reference

6 September 2017

2095-2103

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3996-8

6 September 2017

0 references

cites work

Report of incidence and mortality in china cancer registries, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

The regulation of genes and genomes by small RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

Functional significance of aberrantly expressed microRNAs in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

MiR-378a-3p enhances adipogenesis by targeting mitogen-activated protein kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3996-8

[MicroRNAs and prostate cancer]

21 January 2018

1 reference

12 December 2020

Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation

1 reference

12 December 2020

MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation

1 reference

12 December 2020

Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients

1 reference

12 December 2020

[miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin-like growth factor 1 receptor].

1 reference

12 December 2020

Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions

1 reference

12 December 2020

10.1007/S13277-015-3996-8

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference